# Docetaxel and Oxaliplatin in Treating Patients With Metastatic or Recurrent Solid Tumor

> **NCT00004243** · PHASE1 · COMPLETED · sponsor: **City of Hope Medical Center**

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** docetaxel
- **DRUG:** oxaliplatin

## Key facts

- **NCT ID:** NCT00004243
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-03
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2010-01-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004243

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004243, "Docetaxel and Oxaliplatin in Treating Patients With Metastatic or Recurrent Solid Tumor". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00004243. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*